DOSEF
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Aug 14 closing price
Capitalization
1.63M
NKTX
Price
$2.26
Change
+$0.13 (+6.10%)
Updated
Sep 5 closing price
Capitalization
160.52M
60 days until earnings call
Interact to see
Advertisement

DOSEF vs NKTX

Header iconDOSEF vs NKTX Comparison
Open Charts DOSEF vs NKTXBanner chart's image
Doseology Sciences
Price$1.00
Change-$0.02 (-1.96%)
Volume$1.86K
Capitalization1.63M
Nkarta
Price$2.26
Change+$0.13 (+6.10%)
Volume$437.49K
Capitalization160.52M
DOSEF vs NKTX Comparison Chart in %
Loading...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOSEF vs. NKTX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DOSEF: $1.00 vs. NKTX: $2.26)
Brand notoriety: DOSEF and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 99% vs. NKTX: 83%
Market capitalization -- DOSEF: $1.63M vs. NKTX: $160.52M
DOSEF [@Biotechnology] is valued at $1.63M. NKTX’s [@Biotechnology] market capitalization is $160.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • DOSEF’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both DOSEF and NKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOSEF’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • DOSEF’s TA Score: 3 bullish, 1 bearish.
  • NKTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than NKTX.

Price Growth

DOSEF (@Biotechnology) experienced а 0.00% price change this week, while NKTX (@Biotechnology) price change was +6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

NKTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($161M) has a higher market cap than DOSEF($1.63M). DOSEF YTD gains are higher at: 611.744 vs. NKTX (-9.237). DOSEF has higher annual earnings (EBITDA): -296.52K vs. NKTX (-119.2M). NKTX has more cash in the bank: 290M vs. DOSEF (820K). DOSEF has less debt than NKTX: DOSEF (0) vs NKTX (78.5M). DOSEF has higher revenues than NKTX: DOSEF (46.7K) vs NKTX (0).
DOSEFNKTXDOSEF / NKTX
Capitalization1.63M161M1%
EBITDA-296.52K-119.2M0%
Gain YTD611.744-9.237-6,623%
P/E RatioN/AN/A-
Revenue46.7K0-
Total Cash820K290M0%
Total Debt078.5M-
TECHNICAL ANALYSIS
Technical Analysis
DOSEFNKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
58%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
56%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
44%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YETI36.310.10
+0.28%
YETI Holdings
AC30.92N/A
N/A
Associated Capital Group
L96.64-0.89
-0.91%
Loews Corp
IKT1.67-0.04
-2.34%
Inhibikase Therapeutics
BNZI2.46-0.35
-12.46%
Banzai International Inc

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and PHGE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
PHGE - DOSEF
31%
Poorly correlated
-0.04%
BYSI - DOSEF
27%
Poorly correlated
+1.09%
ALDX - DOSEF
27%
Poorly correlated
+0.54%
NKTX - DOSEF
25%
Poorly correlated
+6.10%
CELC - DOSEF
22%
Poorly correlated
+2.23%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+6.10%
FATE - NKTX
48%
Loosely correlated
+3.81%
BEAM - NKTX
48%
Loosely correlated
+12.62%
SYRE - NKTX
47%
Loosely correlated
+0.06%
CRBU - NKTX
47%
Loosely correlated
+1.08%
IMNM - NKTX
44%
Loosely correlated
+7.35%
More